CVE-2026-24165 NVIDIA CVE debrief

Who should care

Users of NVIDIA BioNeMo Framework, operators, and security teams should be aware of this vulnerability and take necessary precautions to mitigate the risk. Affected deployments should be identified, and owners should be assigned for follow-up. Compensating controls should be reviewed for exposed systems while remediation is scheduled and verified.

Technical summary

The vulnerability exists in the NVIDIA BioNeMo Framework, specifically in the deserialization process. An attacker could exploit this vulnerability by providing malicious data, potentially leading to code execution, denial of service, information disclosure, and data tampering. The vulnerability has a CVSS score of 7.8 and is considered HIGH severity. Users should review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.

Defensive priority

High priority should be given to patching this vulnerability, as it has a high CVSS score and could lead to significant impacts if exploited. Confirmed affected product deployments should be prioritized for patching.

Recommended defensive actions

• Apply the patch provided by NVIDIA
• Restrict access to the affected system
• Monitor for suspicious activity
• Implement compensating controls
• Verify system inventory and configuration

Evidence notes

The CVE record was published on 2026-03-31T17:16:31.727Z and last modified on 2026-07-24T20:10:00.147Z. The NVD entry is currently Analyzed. This vulnerability affects NVIDIA BioNeMo, which is a platform for building and deploying AI models. Users should verify their system inventory and configuration to determine if they are affected. The CVE record and NVD entry provide additional context and details about the vulnerability.

Official resources